Health CanadaGeneral Alert
Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) f...
Published: November 28, 2011Recall ID: 22981Category: generalCountry: Canada
Product Description & Identification
Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label
Additional Source Details
| Field | Value |
|---|---|
| N I D | 22981 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-directs-hoffmann-roche-remove-use-avastin-bevacizumab-treatment |
| Title | Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2011-11-28 |
| Organization | Communications and Public Affairs Branch |